ArticleRSC advances2025

New nicotinamide-thiadiazol hybrids as VEGFR-2 inhibitors for breast cancer therapy: design, synthesis and

Walid E Elgammal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.